I'm liking this stock within 60 days of earnings. It's trading range falls $1.50 to $2.00. Any buying in here is a solid buy IMO. They have so much in the pipeline. GLTA
income stmt looks brutal and they have increased their shares by over 100% in the past 9 mths. balance sheet ok. seems they don't know what they are doing.
income stmt looks brutal and they have increased their shares by over 100% in the past 9 mths. balance sheet ok. seems they don't know what they are doing.
I should have put out my disclaimer that this is a biotech and all biotechs are quite risky.
I can't argue with your commentary. That's a typical biotech profile. They invest aggressively into life-altering products. When they work, this pops. Even so, this is a value when you look at it's trading range. To each their own. Good luck to you.